🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 22 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 03/11/2008 | 7,86 | 8,42 | 7,07 | 7,15 | -7,73% | 17,14% | 117.927 |
| 31/10/2008 | 6,18 | 7,94 | 6,06 | 7,75 | +25,46% | 30,30% | 361.343 |
| 30/10/2008 | 6,21 | 6,81 | 5,76 | 6,18 | +1,85% | 16,87% | 75.528 |
| 29/10/2008 | 5,50 | 6,81 | 4,72 | 6,06 | +11,72% | 38,09% | 183.517 |
| 28/10/2008 | 5,43 | 6,33 | 4,12 | 5,43 | +2,84% | 40,69% | 1.311.040 |
| 27/10/2008 | 6,51 | 7,04 | 5,28 | 5,28 | -20,34% | 27,01% | 95.859 |
| 24/10/2008 | 6,66 | 7,26 | 6,44 | 6,63 | -7,33% | 12,36% | 48.838 |
| 23/10/2008 | 7,52 | 7,75 | 6,40 | 7,15 | -4,98% | 17,91% | 79.322 |
| 22/10/2008 | 7,60 | 8,12 | 7,22 | 7,52 | -2,43% | 11,82% | 97.489 |
| 21/10/2008 | 7,94 | 8,12 | 7,45 | 7,71 | -5,51% | 8,49% | 140.289 |
| 20/10/2008 | 7,64 | 8,20 | 7,45 | 8,16 | +9,55% | 9,80% | 166.578 |
| 17/10/2008 | 7,41 | 7,82 | 6,55 | 7,45 | -1,97% | 17,17% | 324.741 |
| 16/10/2008 | 7,22 | 7,82 | 6,63 | 7,60 | +6,84% | 16,58% | 218.703 |
| 15/10/2008 | 7,67 | 8,23 | 6,89 | 7,11 | -8,21% | 17,56% | 184.559 |
| 14/10/2008 | 7,67 | 8,08 | 7,34 | 7,75 | +1,97% | 9,76% | 108.523 |
| 13/10/2008 | 7,49 | 7,86 | 7,00 | 7,60 | +5,73% | 11,50% | 285.174 |
| 10/10/2008 | 6,63 | 7,19 | 5,95 | 7,19 | +3,78% | 18,64% | 507.537 |
| 09/10/2008 | 7,67 | 7,94 | 6,77 | 6,92 | -7,50% | 15,12% | 127.225 |
| 08/10/2008 | 7,64 | 8,23 | 7,41 | 7,49 | -2,44% | 10,78% | 221.187 |
| 07/10/2008 | 8,42 | 9,13 | 7,49 | 7,67 | -6,39% | 19,56% | 162.197 |
| 06/10/2008 | 8,61 | 9,13 | 7,82 | 8,20 | -9,50% | 15,22% | 300.803 |
| 03/10/2008 | 9,69 | 10,18 | 7,90 | 9,06 | -4,35% | 23,55% | 351.191 |
| 02/10/2008 | 10,89 | 11,00 | 9,43 | 9,47 | -13,95% | 14,43% | 227.947 |
| 01/10/2008 | 10,89 | 11,19 | 10,85 | 11,00 | -0,34% | 3,09% | 62.704 |
| 30/09/2008 | 11,00 | 11,27 | 10,44 | 11,04 | +1,72% | 7,48% | 74.192 |
| 29/09/2008 | 11,34 | 11,64 | 10,52 | 10,85 | -5,23% | 9,90% | 154.396 |
| 26/09/2008 | 11,08 | 11,60 | 10,97 | 11,45 | +0,66% | 5,74% | 135.614 |
| 25/09/2008 | 11,79 | 11,87 | 10,74 | 11,38 | -2,56% | 9,52% | 561.878 |
| 24/09/2008 | 11,64 | 12,24 | 11,42 | 11,68 | +0,65% | 7,07% | 103.848 |
| 23/09/2008 | 12,88 | 12,88 | 11,60 | 11,60 | -7,74% | 9,88% | 133.984 |